MMI, a robotics company dedicated to expanding treatment options and improving clinical outcomes for patients with complex conditions, announced the commercial launch of its Robotic Suture in the U.S. The first suture purpose-built for the Symani Surgical System represents MMI’s continued innovation in microsurgery and is suitable for cases where delicate suturing is required.

Developed in partnership with Kono Seisakusho Co., Ltd. (Crownjun), a global leader in microsurgical sutures, the Robotic Suture features a shorter suture length and needle enhancements tailored to robotic techniques. It is designed to go beyond traditional suture capabilities with improved handling, streamlined workflow, and delivery of consistent performance during robotic anastomosis.

“While Symani continues to push the boundaries of what’s possible with the human hand at the micro scale, we see a clear path to further enhance surgical performance through technologies optimised for robotic microsurgery,” said Mark Toland, CEO of MMI. “The introduction of advanced technology, such as robotics, is driving continued demand for innovation in microsurgery. The suture expands that ecosystem with a solution that further supports surgeons and their patients with enhanced precision, efficiency, and outcomes.”

“Our role has always been to advance surgery by solving needs at the smallest scale,” said Junichi Kono, President of Kono Seisakusho Co., Ltd. “For years, we have developed microsurgical sutures by listening closely to surgeons and turning highly specialised demands into practical innovation. Together with MMI, we have applied that same philosophy to robotic microsurgery, creating a suture solution that supports greater precision, control, and consistency in demanding procedures.”